^
Association details:
Biomarker:No biomarker
Cancer:Thymic Carcinoma
Drug:gemcitabine (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Thymomas and Thymic Carcinomas: PRICIPLES OF SYSTEMIC THERAPY...Preferred…Gemcitabine ± capecitabine...